Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data
Christine L Baker,1 Kelly H Zou,1 Jun Su21Pfizer Inc., New York, NY, USA; 2Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USABackground: Treatment of stable chronic obstructive pulmonary disease (COPD) with long-acting bronchodilator (LABD) medications is recommended by the 2014 Global i...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-05-01
|
| Series: | International Journal of COPD |
| Online Access: | http://www.dovepress.com/long-acting-bronchodilator-use-after-hospitalization-for-copd-an-obser-a16627 |